These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4159123)

  • 1. [Clinical study of the effect of prostate extracts].
    Costa J; Guedes JM; Reis MO
    J Med (Oporto); 1965 Dec; 58(196):1024-7. PubMed ID: 4159123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urine flowmetry in patients with prostatic adenoma treated with Raveron].
    Steinmetz L; Adamkiewicz K
    Pol Przegl Chir; 1974 Oct; 46(10A):1375-82. PubMed ID: 4139698
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of urination disorders with Raveron].
    Ichim V
    Z Urol Nephrol; 1970 Apr; 63(4):255-60. PubMed ID: 4109019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment of prostatic adenoma. Urinary flow data].
    Giglio V; Campo B; Motta M
    Minerva Urol; 1972; 24(3):104-7. PubMed ID: 4141047
    [No Abstract]   [Full Text] [Related]  

  • 5. [Double-blind test on the therapeutic effects of a prostatic extract in the clinical syndrome of prostatic adenoma].
    Arduini M; Trucchi E
    Minerva Urol; 1972; 24(5):167-72. PubMed ID: 4141050
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medical treatment of fibroadenomatous hypertrophy of the prostate with a new plant substance].
    Maver A
    Minerva Med; 1972 May; 63(37):2126-36. PubMed ID: 4113157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Raveron treatment of prostatic adenoma in the light of uroflowmetry (on the basis of 20 cases)].
    Janosz F; Zieliński J
    Pol Przegl Chir; 1975 Nov; 47(11A):1441-4. PubMed ID: 54910
    [No Abstract]   [Full Text] [Related]  

  • 8. [On drug therapy of prostatic hypertrophy].
    Rieben W
    Praxis; 1967 Jul; 56(30):1042-7. PubMed ID: 4180980
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of raveron and levorin on urination recovery in prostatic adenoma and chronic prostatitis].
    Savin VF; Antonov NM; Arkannikov AB
    Urol Nefrol (Mosk); 1982; (2):22-4. PubMed ID: 6177084
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conservative and surgical management of prostatic diseases].
    Hubmann R; Opelt B
    Internist (Berl); 1968 May; 9(5):207-13. PubMed ID: 4178136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Conservative therapy of prostatic hyperplasia with urinary retention].
    Djulepa J
    Med Welt; 1983 Dec; 34(48):1377-9. PubMed ID: 6197601
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hypertrophy of the prostate with gestagens].
    Vahlensieck W; Gödde S
    Munch Med Wochenschr; 1968 Jun; 110(26):1573-7. PubMed ID: 4182927
    [No Abstract]   [Full Text] [Related]  

  • 13. Breakthrough treatment for prostate enlargement.
    Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):3, 7. PubMed ID: 12712965
    [No Abstract]   [Full Text] [Related]  

  • 14. [Administration of afala preparation in urological practice].
    Neĭmark AI; Isaenko VI; Iakovets IaV; Simashkevich AV; Aliev RT
    Urologiia; 2009; (3):67-70. PubMed ID: 19673125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The current approach to the management of benign hypertrophy of the prostate].
    Abbou CC; Salomon L; Chopin D; Ravery V; Haillot O
    Ann Urol (Paris); 1996; 30(6-7):294-301; discussion 302-10. PubMed ID: 9092383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience in the use of doxazosin in patients with benign hyperplasia of the prostate].
    Lopatkin NA; Loran OB; Pushkar' DIu; Perepanova TS; Tevlin KP
    Urol Nefrol (Mosk); 1998; (3):3-5. PubMed ID: 9644978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uroselectivity of alpha-1 antagonism in the treatment of benign prostatic hypertrophy: on the pharmacologic concept of the clinical approach].
    Jolliet P; Bourin M
    Therapie; 1998; 53(1):61-6. PubMed ID: 9773101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrophoretic studies of normal prostate homogenate and of adenoma, with special reference to the prostate homogenate of patients treated with Raveron].
    Fabris P; Mori G; Ingrami A
    Arch Ital Urol; 1966 Aug; 38(5):391-404. PubMed ID: 4169901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urination disorders in middle-aged men. Adenoma and carcinoma of the prostate].
    Nagel R
    Med Monatsschr; 1968 Apr; 22(4):153-9. PubMed ID: 4177968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.